Biocryst Pharmaceuticals buy Needham & Company LLC
Start price
20.04.23
/
50%
€6.67
Target price
20.04.24
€12.77
Performance (%)
-38.50%
End price
21.04.24
€4.10
Summary
This prediction ended on 21.04.24 with a price of €4.10. The BUY prediction by Needham___Company_LL for Biocryst Pharmaceuticals performed very badly with a performance of -38.50%. Needham___Company_LL has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Biocryst Pharmaceuticals | -1.354% | -1.354% | -0.753% |
iShares Core DAX® | -5.585% | -6.284% | 8.869% |
iShares Nasdaq 100 | -7.241% | -13.117% | 18.200% |
iShares Nikkei 225® | -8.933% | -10.904% | 2.614% |
iShares S&P 500 | -6.148% | -7.562% | 17.896% |
Comments by Needham___Company_LL for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Current prediction by Needham___Company_LL for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.70
06.11.23
06.11.23
€11.17
06.11.24
06.11.24
19.96%
11:31
11:31
Stopped prediction by Needham___Company_LL for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.98
07.05.24
07.05.24
€11.13
07.05.25
07.05.25
37.34%
11:31
11:31
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.00
08.01.24
08.01.24
€10.95
08.01.25
08.01.25
13.97%
11:31
11:31
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.47
03.08.23
03.08.23
€10.96
03.08.24
03.08.24
-1.24%
04.08.24
04.08.24